A. “Lipids in Brain Aging and Alzheimer’s Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed),” (RFA-AG-23-009, National Institute on Aging, application deadline June 14, 2022).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-009.html
B. “HEAL Initiative: Planning Grants for Efficacy or Effectiveness Trials of Recovery Support Services for Individuals Treated with Medications for Opioid Use Disorder (R34 Clinical Trial Optional),” (RFA-DA-22-034, National Institute on Aging, in conjunction with other agencies, application deadline March 10, 2022).
grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-034.html
C. “HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders (R01 Clinical Trial Optional),” (RFA-DA-22-046, National Institute on Aging, in conjunction with other agencies, application deadline March 10, 2022).
grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-046.html
D. “HEAL Initiative: Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional),” (RFA-DA-22-043, National Institute on Aging, in conjunction with other agencies, application deadline March 10, 2022).
grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-043.html
E. “HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional),” (RFA-DA-22-047, National Institute on Aging, in conjunction with other agencies, application deadline March 10, 2022). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “HEAL Initiative: Pilot & Feasibility Trials to Improve Prevention and Treatment Service Delivery for Polysubstance Use (R34 Clinical Trial Optional),” (RFA-DA-22-048).
